Home » Topics » BioWorld Science

BioWorld Science
RSS

Galmed reports 1-year data from phase IIb study of Aramchol in NASH

June 13, 2018

E-Scape Bio obtains rights to S1P5 receptor agonists from AbbVie for lysosomal storage disorders

June 13, 2018

FDA approves Keytruda for recurrent or metastatic cervical cancer whose tumors express PD-L1

June 13, 2018

IMPACT Therapeutics identifies WEE1hu inhibitors

June 13, 2018

Bristol-Myers Squibb patents TYK2 inhibitors

June 13, 2018

4D Pharma gains further clearances to conduct phase II study of Blautix for IBS

June 13, 2018

Bioelectron Technology presents new imidazole compounds

June 13, 2018

CStone initiates pivotal studies of CS-1001 in China

June 13, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

Cynata reports 6-month data from cohort A of phase I trial of CYP-001 in acute GvHD

June 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...